Private Label DNA Repair Enzyme Serum Manufacturer Low MOQ

Do DNA repair enzyme serums require special FDA or EU regulatory approval before I can sell them?

By Blake Mereby · Last reviewed October 5, 2026

In the United States, cosmetics — including enzyme serums — do not require pre-market approval from the FDA. However, the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) introduced new mandatory requirements: facility registration, product listing, serious adverse event reporting, and substantiated safety data. These apply to virtually all cosmetic brands selling in the U.S., including small brands and DTC-only companies.

The deeper regulatory risk for DNA repair enzyme serums in the U.S. is claim classification. The FDA distinguishes cosmetics (products that alter appearance without affecting the body's structure or function) from drugs (products that affect the body's structure or function). A serum marketed to "repair UV-damaged DNA" is making a biological mechanism claim that the FDA would likely classify as a drug claim, triggering the OTC drug monograph or New Drug Application pathway — neither of which is practical for a typical indie beauty brand. Working with a cosmetic regulatory consultant to craft claims like "helps minimize the visible effects of sun-stressed skin" or "supports the skin's natural renewal process" keeps your product on the cosmetic side of the line while still communicating the serum's differentiated positioning.

In the European Union, cosmetics are governed by Regulation (EC) No 1223/2009. There is no pre-market approval, but there are mandatory requirements: a Cosmetic Product Safety Report (CPSR) prepared by a qualified cosmetic safety assessor, a Product Information File (PIF), appointment of an EU Responsible Person, and notification via the EU Cosmetic Products Notification Portal (CPNP) before placing the product on the market. EU claim rules (Regulation EC No 655/2013) prohibit claims that imply a medicinal effect, so the same DNA repair language issues apply.

For Canada, Health Canada classifies some enzyme-based products as Natural Health Products rather than cosmetics, particularly if the claim references cellular or DNA-level activity. An NPN (Natural Product Number) application may be required — a process that takes 6–18 months. Confirm your Canada regulatory status before investing in bilingual label artwork.

For markets like South Korea, China (NMPA), and Japan, enzyme actives in serums may require additional dossier submissions or ingredient pre-approval. China, in particular, has a new cosmetic ingredient notification pathway for ingredients not already on the IECIC (Inventory of Existing Cosmetic Ingredients in China), and novel enzymes may qualify as new cosmetic ingredients requiring a full safety dossier.

The most common mistake first-time founders make is finalizing label artwork with the claim language before running it by a regulatory consultant. Reprinting labels is cheap; reprinting after a warning letter or retailer rejection is expensive and delays launch. AJ Cosmo Labs connects you with manufacturers who have in-house or partner regulatory support, so claim review is part of the manufacturing workflow rather than an afterthought.

Read the full guide on Private Label DNA Repair Enzyme Serum Manufacturer Low MOQ →

More about Private Label DNA Repair Enzyme Serum Manufacturer Low MOQ

Tell us about your product

Tell us what you're selling and where. You can hire a vetted cosmetic chemist on AJ Cosmo Labs to review your formula and labeling. Starting is free.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app